Market revenue in 2023 | USD 522.0 million |
Market revenue in 2030 | USD 1,015.9 million |
Growth rate | 10% (CAGR from 2023 to 2030) |
Largest segment | Outpatient facilities |
Fastest growing segment | Home Care |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Hospitals, Outpatient Facilities, Home Care, Research & Manufacturing |
Key market players worldwide | BD, Danaher Corp, Koninklijke Philips NV, Qiagen NV, Thermo Fisher Scientific Inc, Myriad Genetics Inc, Argon Medical Devices, Roche Holding AG ADR, Hologic Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to breast cancer diagnostics market will help companies and investors design strategic landscapes.
Outpatient facilities was the largest segment with a revenue share of 64.16% in 2023. Horizon Databook has segmented the South Korea breast cancer diagnostics market based on hospitals, outpatient facilities, home care, research & manufacturing covering the revenue growth of each sub-segment from 2018 to 2030.
South Korea breast cancer diagnostics market is estimated to experience lucrative growth over the forecast period. Breast cancer is the leading cause of deaths in women in South Korea. Thus, rapid diagnostic techniques are essential for early diagnosis of cancer and in deciding appropriate treatment options.
AI-assisted technologies for diagnosis of breast cancer by radiologists makes the diagnosis process easier and facilitates faster & more accurate diagnosis. As per NCBI report of 2020, the condition impacted 24,010 women in 2019, with an incidence rate of 92.9 per 100,000.
According to the Breast Cancer in Asia report, this country has the highest number of mammography units per woman aged 50 to 69. It also provides free mammography for women in the bottom half of national income distribution and contacts all of those who are scheduled to undergo the procedure in a given year.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea breast cancer diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into South Korea breast cancer diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account